pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 16·1 min read
save

CMS proposes new payment framework for clinical software and AI to link reimbursement with patient outcomes

Jul 16, 2026·read at STAT ↗RegulatoryNeutral

The Centers for Medicare & Medicaid Services (CMS) has released proposed rules for 2027 that would create a standardized payment structure for clinical software and artificial intelligence tools. The agency says the new model would tie reimbursement to the impact these technologies have on patient outcomes.

For years Medicare has struggled to fit software‑based tools, such as algorithms that predict cardiac risk or map prostate cancer spread, into its traditional cost‑based payment system. The proposed changes aim to address that gap.

The proposal is presented as an interim step, but CMS signals that it could lead to broader reforms in how digital health solutions are funded across the health‑care system.

The announcement is part of a series examining how emerging AI tools affect health‑care affordability and long‑term patient health.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: CMS signals intent to revamp how it pays for clinical software and AI”

read at STAT ↗
557 words · retrieved Jul 16
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
BARRUltragenyx Pharmaceutical Inc.
topics
Oncology2Prostate Cancer2ImmunologyInfectious DiseaseMultiple SclerosisRare Disease

related stories

  • Aug 5MRI is standard for diagnosing prostate cancer in most western countries. But most U.S. men don’t get themSTAT
  • Jul 15STAT+: New study untangles how Epstein-Barr viral infection triggers immune response in multiple sclerosisSTAT
  • May 7Sylvester Comprehensive Cancer Center Identifies a Screening Gap to Prevent a Type of Leukemia in the U.S.onclive
  • Dec 22Fierce Biotech Fundraising Tracker '26: Superluminal snags $60M; AusperBio adds $120MFierce Biotech
  • 15h agoNovartis may cut around 130 in Switzerland while relocating biologics productionBioSpace